Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Human Metabolome Technologies Inc amends consolidated mid-year outlook for FY 2015


Thursday, 12 Jun 2014 03:30am EDT 

Human Metabolome Technologies Inc:Says the company affirmed the consolidated mid-year outlook for revenue at 242 million yen for FY ending March 2015.Operating profit forecast decreased to a loss of 164 million yen from a loss of 148 million yen.Ordinary profit forecast decreased to a loss of 163 million yen from a loss of 144 million yen.Net profit forecast decreased to a loss of 161 million yen from a loss of 142 million yen.Earnings per share decreased to a loss of 30.66 yen from a loss of 27.62 yen.Comments that increased research and development funds for liver disease diagnosis kit development and increased maintenance expenses are the main reasons for the forecast. 

Company Quote

1189.0
29.0 +2.50%
27 Mar 2015